Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on January 27, 2016, to report its financial results for the fourth quarter and full year ended December 31, 2015. This filing primarily serves to inform investors about the company's performance and financial condition as of that period. The press release, furnished as an exhibit, contains the detailed financial information and is the core of this report's disclosure. Investors should refer to this press release for specifics on revenue, profitability, and other key financial metrics. While the 8-K itself is a brief notification, it signifies the company's commitment to timely financial reporting. The information contained within the referenced press release would provide insights into the company's operational success, any significant year-over-year changes, and potentially management's outlook for the upcoming fiscal year. For a comprehensive understanding, investors need to examine the financial data and commentary presented in the accompanying press release.
Key Highlights
- 1Elevance Health (then Anthem, Inc.) announced its financial results for Q4 and full year 2015.
- 2The 8-K filing is dated January 27, 2016, and reports on the period ending December 31, 2015.
- 3The primary disclosure is through a press release furnished as Exhibit 99.1.
- 4This filing informs investors about the company's financial performance.
- 5No new material business events, acquisitions, or significant strategic changes were reported in this 8-K itself, beyond the routine financial results announcement.
- 6Information furnished in the 8-K is not deemed 'filed' for Section 18 purposes unless specifically stated.